Spear Pharmaceuticals is a specialty pharmaceutical company focused in the dermatology market. We develop branded and bioequivalent products that help people restore their skin's health. We manufacture our products in the United States in facilities inspected and approved by the FDA. Our commitment to quality has resulted in FDA approval for seven first-to-market bioquivalent dermatologicals, with several more in the pipeline.
Looking for a particular Spear Pharmaceuticals employee's phone or email?
The Spear Pharmaceuticals annual revenue was $7 million in 2026.
Rachel Phillips is the VP, New Product Development of Spear Pharmaceuticals.
3 people are employed at Spear Pharmaceuticals.
Spear Pharmaceuticals is based in Randolph, New Jersey.
The NAICS codes for Spear Pharmaceuticals are [325, 3254, 32, 32541].
The SIC codes for Spear Pharmaceuticals are [283, 28].